newsfilter
← Latest News
GlobeNewswire·

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory